HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masaaki Oka Selected Research

Pyrimidine Phosphorylases

3/2008[Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masaaki Oka Research Topics

Disease

84Neoplasms (Cancer)
04/2021 - 03/2002
43Hepatocellular Carcinoma (Hepatoma)
04/2021 - 07/2002
27Colorectal Neoplasms (Colorectal Cancer)
08/2017 - 09/2002
23Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 03/2002
18Neoplasm Metastasis (Metastasis)
01/2017 - 11/2002
14Breast Neoplasms (Breast Cancer)
10/2018 - 08/2002
11Stomach Neoplasms (Stomach Cancer)
01/2018 - 02/2002
10Esophageal Neoplasms (Esophageal Cancer)
07/2014 - 07/2004
5Infections
02/2015 - 07/2004
5Colonic Neoplasms (Colon Cancer)
11/2013 - 10/2004
5Carcinogenesis
11/2011 - 07/2004
5Carcinoma (Carcinomatosis)
11/2010 - 02/2002
5Esophageal Squamous Cell Carcinoma
01/2010 - 10/2003
3Surgical Wound Infection
10/2019 - 07/2012
3Pneumonia (Pneumonitis)
09/2015 - 11/2013
3Adenocarcinoma
01/2015 - 05/2002
3Hypoxia (Hypoxemia)
10/2008 - 04/2007
2Liver Neoplasms (Liver Cancer)
10/2019 - 01/2010
2Hypersensitivity (Allergy)
05/2018 - 05/2005
2Liver Diseases (Liver Disease)
01/2016 - 10/2003
2Sarcoma (Soft Tissue Sarcoma)
01/2015 - 10/2014
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2015 - 01/2008
2Thrombosis (Thrombus)
11/2013 - 10/2003
2Tracheoesophageal Fistula
11/2013 - 11/2009
2Chromosomal Instability (Chromosome Stability)
07/2012 - 10/2010
2Aneuploidy (Aneuploid)
07/2012 - 10/2010
2Inflammation (Inflammations)
01/2010 - 10/2008
2Lymphatic Metastasis
11/2009 - 11/2008
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2008 - 05/2003
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2007 - 10/2003
2Ascites
10/2005 - 10/2003

Drug/Important Bio-Agent (IBA)

23Proteins (Proteins, Gene)FDA Link
04/2021 - 05/2002
19DNA (Deoxyribonucleic Acid)IBA
01/2018 - 01/2002
16Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2003
15Peptides (Polypeptides)IBA
08/2017 - 03/2002
14Messenger RNA (mRNA)IBA
04/2021 - 02/2002
8Irinotecan (Camptosar)FDA LinkGeneric
07/2017 - 11/2008
8OligonucleotidesIBA
07/2005 - 07/2002
7Fluorouracil (Carac)FDA LinkGeneric
10/2014 - 11/2002
7CytokinesIBA
07/2014 - 01/2003
6HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
04/2021 - 12/2003
6HLA-A Antigens (HLA-A)IBA
08/2017 - 03/2014
6GemcitabineFDA Link
01/2017 - 12/2006
6Protein Subunit VaccinesIBA
01/2017 - 03/2002
6LentinanIBA
01/2016 - 11/2008
5VaccinesIBA
08/2017 - 03/2002
4AntigensIBA
04/2021 - 07/2008
4Cancer VaccinesIBA
10/2014 - 12/2010
4EnzymesIBA
08/2014 - 12/2002
4doxifluridineIBA
08/2013 - 11/2008
4Imatinib Mesylate (Gleevec)FDA Link
11/2012 - 11/2009
4Cisplatin (Platino)FDA LinkGeneric
11/2009 - 10/2003
3Carrier Proteins (Binding Protein)IBA
01/2018 - 03/2008
3Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 06/2013
3HLA Antigens (Human Leukocyte Antigens)IBA
08/2017 - 02/2009
3Cetuximab (Erbitux)FDA Link
10/2015 - 02/2011
3Tumor Biomarkers (Tumor Markers)IBA
10/2015 - 04/2007
3Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2015 - 03/2008
3Leucovorin (Folinic Acid)FDA Link
10/2014 - 02/2011
3EpitopesIBA
08/2014 - 12/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 02/2008
3AutoantibodiesIBA
07/2013 - 07/2006
3AntibodiesIBA
07/2013 - 04/2007
3PicibanilIBA
11/2010 - 10/2003
3Cell-Free Nucleic AcidsIBA
01/2010 - 11/2006
3Iopamidol (Isovue)FDA LinkGeneric
12/2005 - 02/2004
2Anti-Bacterial Agents (Antibiotics)IBA
10/2019 - 05/2018
2Estrogen ReceptorsIBA
10/2018 - 02/2002
2Pharmaceutical PreparationsIBA
07/2017 - 09/2014
2Mucin-1 (CA 15-3 Antigen)IBA
01/2017 - 10/2015
2Interleukin-10 (Interleukin 10)IBA
07/2014 - 10/2005
2Interleukin-2 (IL2)IBA
06/2014 - 11/2002
2Immunologic Factors (Immunomodulators)IBA
01/2013 - 11/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2013 - 10/2005
2Epirubicin (Ellence)FDA LinkGeneric
01/2013 - 10/2005
2Protein Isoforms (Isoforms)IBA
11/2011 - 06/2008
2Immunoglobulin G (IgG)IBA
12/2010 - 04/2007
2Biological ProductsIBA
10/2010 - 02/2008
2squamous cell carcinoma-related antigenIBA
01/2010 - 11/2009
2Indicators and Reagents (Reagents)IBA
07/2008 - 11/2004
2Interleukin-12 (IL 12)IBA
10/2005 - 10/2003
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
09/2005 - 01/2004
2Complementary DNA (cDNA)IBA
07/2004 - 02/2002
2BerberineIBA
11/2003 - 05/2002
2Matrix Metalloproteinases (MMPs)IBA
09/2003 - 12/2002

Therapy/Procedure

26Drug Therapy (Chemotherapy)
11/2017 - 11/2002
25Therapeutics
04/2021 - 02/2002
13Immunotherapy
01/2018 - 03/2002
13Hepatectomy
01/2016 - 10/2003
6Lymph Node Excision (Lymph Node Dissection)
11/2014 - 06/2005
6Esophagectomy
07/2014 - 12/2005
6Radiotherapy
01/2014 - 11/2007
3Gastrectomy
01/2018 - 11/2014
3Adjuvant Chemotherapy
01/2013 - 10/2005
3Oral Administration
01/2013 - 10/2005
2Combination Drug Therapy (Combination Chemotherapy)
12/2013 - 11/2009
2Neoadjuvant Therapy
11/2013 - 11/2007
2Length of Stay
08/2012 - 07/2012
2Lasers (Laser)
10/2011 - 10/2010
2Massage (Zone Therapy)
06/2005 - 02/2004